Global Biopharmaceutical Industry Commitment
to Address Coronavirus Public Health Crisis

As part of the global health community, biopharmaceutical companies are committed to playing the greatest possible role in the rapid, global response to COVID-19. Learn about our commitments and how we're leading the way in developing diagnostics, treatments and vaccines for COVID-19.

Back to List

Celgene

celgene.com

COLLABORATIONS

SHOWING 5 of 10 COLLABORATIONS

See All

Access Accelerated Initiative

Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...

Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited, UCB
 
Read More

SHOWING 5 of 10 COLLABORATIONS

See All